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The effect of acute renal failure (ARF) induced by ischemia/
reperfusion (I/R) of rat kidney on the expression of organic
anion transporters (OATs) was examined. The level of serum
indoxyl sulfate (IS), a uremic toxin and substrate of OATs in
renal tubules, shows a marked increase with the progression
of ARF. However, this increase was significantly attenuated
by ingestion of cobalt. The level of mRNA and protein of
both rOAT1 and rOAT3 were markedly depressed in the
ischemic kidney. The uptake of p-aminohippuric acid (PAH)
and estrone sulfate (ES) by renal slices of ischemic rats
was significantly reduced compared to control rats. Renal
slices taken from ischemic rats treated with cobalt displayed
significantly elevated levels of ES uptake. Cobalt intake did
not affect PAH uptake, indicating the functional restoration
of rOAT3 but not rOAT1. The expression of Naþ /Kþ -ATPase
was markedly depressed in the ischemic kidney, suggesting
that the inward Naþ gradient in renal tubular cells had
collapsed, thereby reducing the outward gradient of
a-ketoglutarate, a driving force of both rOATs. The
decreased expression of Naþ /Kþ -ATPase was significantly
restored by cobalt treatment. Our results suggest that
the downregulation of renal rOAT1 and rOAT3 could be
responsible for the increase in serum IS level of ischemic
rats. Cobalt treatment has a significant protective effect
on ischemia-induced ARF, being accompanied by the
restoration of rOAT3 and/or Naþ /Kþ -ATPase function.
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Together with the liver, the kidney plays a principal role in
the excretion of a wide variety of xenobiotics, including drugs
and toxins, as well as endogenous compounds. In the renal
proximal tubules, several unidirectional solute transport
systems facilitate active secretion of a wide range of
exogenous and endogenous organic ions into urine.1–3
Transport proteins for organic anions and cations localized
at the apical and basolateral plasma membranes of the
proximal tubular cells appear to mediate urinary secretion of
endogenous substances and various drugs.1,4,5 To date, the
structure and function of several members of the organic
anion transporter (OAT) and organic cation transporter
(OCT) gene family (e.g. SLC22A), which mediate trans-
epithelial transport of organic ions, have been character-
ized.1,4,5 It has been suggested that ATP-dependent primary
active transporters, such as multidrug resistance protein/
P-glycoprotein and members of the multidrug resistance-
associated protein gene family, function as efflux pumps of
renal tubular cells to mediate active extrusion of hydrophobic
molecules and anionic conjugates.1,6 Therefore, the func-
tional and molecular variations of these transporters should
have an impact on renal clearance of their substrate drugs,
causing alteration of pharmacokinetics and/or unexpected
adverse side effects of accumulated drugs in the body.
Acute renal failure (ARF) caused by ischemia/reperfusion
(I/R) is a crucial clinical issue. Although progress has been
made in the diagnosis and treatment of patients with
ARF, there is still a high mortality rate associated with this
condition.7–9 I/R-induced ARF is evoked by a complicated
interaction between renal hemodynamics, inflammatory
cytokines, endothelial, and tubular cell injury.10 Although
the kidney receives about 25% of the cardiac output, the
majority goes to the cortex. Therefore even a slight decline in
renal blood flow can lead to hypoxic injury of the medullary
region.11 I/R-induced injury to the renal medulla plays a
significant role in ARF. In fact, the S3 segment of the
proximal tubule in the outer medulla has been shown to be
the most susceptible portion of the kidney to I/R-induced
ARF.12 In a recent report, preconditioning of rats with cobalt
chloride resulted in improvement of ischemic renal injury.13
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Cobalt chloride is thought to act by stabilizing hypoxia-
inducible factor 1, thereby inducing erythropoietin, glycolytic
enzymes, P-glycoprotein, and the glucose transporter.14–17
The serum level of the uremic toxin indoxyl sulfate (IS) is
markedly elevated in uremic patients18 and in 5/6 nephrec-
tomized rats,19 a well-established animal model for chronic
renal failure. IS appears to be a substrate for the baso-
laterally localized transporters OAT1 and OAT3.20,21 In the
5/6 nephrectomized rats, the renal expression of rOAT1
and rOAT3 was markedly downregulated in chronic
renal failure.22,23 In the clinical situation, patients with renal
disease showed a downregulation of hOAT3, which is
thought to be responsible for a decreased urinary excretion
of cefazolin, an anionic cephalosporin antibiotic.24 However,
there is little information concerning the regulation of renal
organic solute transporters in ARF. Such data would be useful
for understanding the pharmacokinetic profile of drugs that
are excreted mainly into the urine during the treatment of
patients with renal impairment.
In this study, we explored the serum levels of IS and the
regulation of OATs mediating urinary excretion of endo-
genous anionic toxins in rats with I/R-induced ARF.
RESULTS
Renal functional data of ischemic rats
Figure 1 summarizes the changes in body weight, blood
urea nitrogen (BUN) and serum creatinine (SCr) level of
sham-operated rats (control) and I/R-induced ARF rats with
and without cobalt chloride in the drinking water. The body
weight of both control and ischemic rats decreased until 12 h
after sham operation or I/R (Figure 1a). The body weight
of control rats recovered to their initial level, whereas
ischemic rats showed a further loss in body weight 24 h after
ischemia. Body weights of sham rats at 48 h was decreased by
cobalt intake. I/R rats also showed a decrease in body weights
at 48 h by cobalt intake. The serum BUN level was markedly
elevated in ischemic rats from 6 h after I/R, but was
significantly depressed by intake of cobalt (Figure 1b). The
SCr level also showed a marked increase in the ischemic rats,
but was significantly suppressed in the ischemic rats given
cobalt (Figure 1c). Cobalt intake had no effect on serum BUN
and SCr levels of control rats. Serum Na level decreased in
ischemic rats, whereas a significant increase in Na level was
observed in rats given cobalt (Table 1). Ischemic rats showed
a significant decrease in serum Cl level at 48 h compared to
control rats. Inclusion of cobalt in the drinking water resulted
in a significant increase in serum Cl levels both in control
and ischemic rats, compared with rats given cobalt-free
water at 48 h. Although the serum K level increased in
ischemic rats, such an increase was partially suppressed upon
ingestion of cobalt.
Figure 2 shows the histological alterations of the kidneys
of control and I/R-induced ARF rats with or without the
cobalt intake. Cobalt intake caused no morphological
changes (Figure 2a and b). I/R caused tubular damage,
tubular dilation, tubular epithelial injury, debris accumula-
tion, and cast formation, mostly around the outer stripe of
the outer medulla (Figure 2c and e). Tubular damage induced
by ischemia was substantially reduced by intake of cobalt
(Figure 2d and f). Semiquantitative scoring analysis
suggested that cobalt intake showed a tendency to protect
renal injury in outer medulla of I/R rats (outer stripe,
P¼ 0.131; inner stripe, P¼ 0.041; Figure 2g and h). These
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Figure 1 | Changes in body weight and the level of BUN and
SCr in control and ischemic rats with/without intake of cobalt.
(a) Body weight of killing over body weight of operation, (b) BUN
and (c) SCr after sham operation (open column) or I/R injury (closed
column). Each column represents the mean7s.e.m. for three to
eight rats. *Po0.05, **Po0.01, significantly different from control
rats at same period. #Po0.05, ##Po0.01, significantly different from
rats without cobalt intake at the same period.
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results suggest that cobalt intake ameliorates I/R-induced
damage to the renal tubules.
Endogenous IS levels in ischemic rats
As shown in Figure 3a, endogenous IS level was markedly
elevated in the ischemic rats compared to that in control rats
from 6 h after I/R. The increase in serum IS was significantly
suppressed by ingestion of cobalt. These findings suggest
that cobalt intake had a partial protective effect against
I/R-induced ARF. Cobalt intake had no effect on the IS
concentration of control rats. Significant correlation between
the level of BUN or SCr with the concentration of serum
IS in control and I/R rats was observed (Figure 3b and c),
suggesting that IS could be an endogenous marker for
evaluating renal dysfunction in ischemic ARF.
mRNA expression of OATs in ischemic rat kidney
The increase in the level of serum IS in ischemic rats suggests
that renal handling of the uremic toxin could be disturbed.
Thus, we examined whether the expression of OATs mRNA
and proteins in the I/R-induced ischemic rat kidney was
altered. Figure 4 shows the relative mRNA expression levels of
rOAT1 and rOAT3 in the kidney of control and ischemic rats
by using the real-time polymerase chain reaction method.
Both rOAT1 and rOAT3 mRNA levels were markedly
depressed in the ischemic rat kidney (Figure 4a and b). The
mRNA levels of rOAT1 and rOAT3 were fractionally higher in
the ischemic rat kidney after ingestion of cobalt.
The effect of I/R-induced ARF on mRNA expression of
rMdr1, a gene encoding P-glycoprotein located at the brush-
border membrane of proximal tubules, was also examined. In
contrast to OATs, rMdr1 mRNA expression was transiently
stimulated at 6 and 12 h after ischemia and then decreased to
the level of control rat kidney (Figure 4c). Cobalt intake had
no effect on the expression of rMdr1 mRNA.
Protein expression of OATs in ischemic rat kidney
Changes in the expression of OAT protein 48 h after ischemia
was examined by Western blot analyses. As observed for the
corresponding mRNA expression, rOAT1 and rOAT3 protein
levels were also depressed in the ischemic rat kidney (Figure
5a and b). Cobalt intake had no significant impact on the
rOAT1 expression in the kidney of both control and ischemic
rats. By contrast, the expression of rOAT3 was significantly
restored by ingestion of cobalt. P-glycoprotein level showed
no significant difference between the control and the
ischemic rats, as found for the rMdr1a mRNA expression.
Naþ /Kþ -ATPase expression was drastically depressed in the
ischemic rat kidney as reported previously,25,26 but was
significantly restored by ingestion of cobalt.
Uptake of PAH and ES by renal slices
To evaluate the functional activity of renal OATs at the
basolateral membrane, we measured the accumulation of
organic anions, p-aminohippuric acid (PAH), and estrone
sulfate (ES), in renal slices prepared from control and
ischemic rat kidney. As shown in Figure 6a and b, the
accumulation of PAH and ES was significantly lower in the
renal slices from ischemic rats, compared to renal slices from
control rats. Renal uptake clearance of PAH and ES was
significantly lower (i.e. reduced to 18 or 48%, respectively) in
ischemic rats compared to control rats (Figure 6c and d).
This result demonstrates that renal uptake of ES, but not
PAH, is significantly restored in slices taken from rats treated
with the cobalt-supplemented water. These findings suggest
that the function of rOAT3, but not rOAT1, is partially
restored by ingestion of cobalt.
DISCUSSION
The mechanisms of ARF involve both vascular and tubular
factors.27 In established ARF, the presence of tubular necrosis
upon histological assessment of the kidney is seen in
occasional tubular cells.7 ARF is characterized by tubular
dysfunction with impaired sodium and water reabsorption
and is associated with the shedding and excretion of proximal
tubule brush-border membranes and epithelial tubule
cells into the urine.9 Following I/R, morphological changes
occur in the proximal tubules, including loss of polarity,
loss of the brush border, and redistribution of integrins
and Naþ /Kþ -ATPase to the apical membrane.7,9,28 Because
secretion of xenobiotics and endogenous uremic toxins is
performed by several transport proteins localized specifically
at the basolateral and brush-border membranes of the
proximal tubular cells, renal tubular damage will adversely
affect excretion of these compounds.
In this study, we have found for the first time that the level
of serum IS is markedly elevated in ischemic rats with I/R-
induced renal injury. IS is thought to stimulate the
progression of chronic renal failure, which is accompanied
by glomerular sclerosis.20 IS appears to induce several genes,
including transforming growth factor-b1 and tissue inhibitor
of metalloproteinase-1, thereby accelerating the progression
of renal sclerosis in subtotal nephrectomized rat kidney.29,30
The observed increase in the concentration of serum
IS in ischemic rats could contribute to acute renal
tubular dysfunction. Because 495% of serum IS is bound
to albumin, IS is excreted mostly into urine via tubular
secretion, rather than via glomerular filtration.31 OATs
have been reported to mediate IS uptake at the baso-
lateral membrane of renal tubules.20,21 Our demonstration
of elevated IS levels in ischemic rat serum encouraged us
Table 1 | Level of serum electrolytes 48 h after I/R
Na (mEq/dl) Cl (mEq/dl) K (mEq/dl)
Control 14270 10071 4.870.2
I/R 13871** 8671** 7.570.9**
Control with cobalt 14571## 10871## 4.870.3
I/R with cobalt 14771* # 10872## 6.370.5*
I/R, ischemia/reperfusion.
Each value represents the mean7s.e.m. for seven to eight rats. *Po0.05, **Po0.01
significantly different from control rats with or without cobalt intake. #Po0.05,
##Po0.01 significantly different from rats without cobalt intake.
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to examine changes in OATs accompanied by I/R of the
rat kidney.
We found that the expression of mRNA and protein of
both rOAT1 and rOAT3 were downregulated in ischemic rat
kidney (Figures 4 and 5). In addition, organic anion
transport activity at the basolateral membrane was signifi-
cantly reduced in the ischemic rat kidney, as demonstrated by
the reduction in the accumulation of PAH and ES into
renal slices (Figure 6). It was reported that OAT1 mediates
renal tubular uptake of PAH and several pharmacological
agents, such as methotrexate, b-lactam antibiotics, and
non-steroidal anti-inflammatory drugs.1 OAT3 appears to
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Figure 2 | Histological alteration of the kidneys of control and ischemic rats with or without cobalt intake at 48 h after ischemia.
(a) Control rats, (b) control rats with cobalt intake, (c) ischemic rats, (d) ischemic rats with cobalt intake, (e) outer stripe of ischemic rats, and
(f) outer stripe of ischemic rats with cobalt intake. (a–d) Hematoxylin–eosin staining low magnification; (e and f) hematoxylin–eosin staining
high magnification. Tubular injury of (g) outer stripe and (h) inner stripe of outer medulla in I/R rats with or without cobalt intake was graded
with an arbitrary score of 0–3. The horizontal solid lines indicate the median. Statistical analyses were performed using the Mann–Whitney’s test.
I/R caused tubular damage to the outer stripe of outer medulla. Cobalt intake reduces tubular damage induced by I/R.
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efficiently mediate ES transport with high affinity in addition
to transporting several anionic compounds such as PAH,
methotrexate, prostaglandin E2, and cyclic adenosine mono
phosphate.1 Therefore, downregulation of both rOAT1
and rOAT3 should account for the decrease in PAH and
ES uptake at the basolateral membrane of tubular cells in
ischemic rat kidney. Intriguingly, we also observed a
significant recovery in the accumulation of ES, but not
PAH, by renal slices derived from I/R-induced rats
given water supplemented with cobalt. In vitro studies
have shown that the contribution of rOAT1 and rOAT3
to the uptake of IS is 38 and 62%, respectively.32 Therefore,
the decrease in serum IS levels in ischemic rats treated
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with and without cobalt intake. (a) High-performance liquid
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Figure 4 | mRNA expression of organic anion transporters and
rMdr1a in ischemic rat kidney. Relative mRNA expression levels
of (a) rOAT1, (b) rOAT3 and (c) rMdr1a in control (open column)
and ischemic rats (closed column) with and without cobalt intake.
The expression level in the control at 6 h was set at 1.0. Each
column represents the mean7s.e.m. for three to eight rats. *Po0.05,
**Po0.01, significantly different from control rats at the same period.
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cobalt might be the result of partially restored rOAT3
function and/or expression.
Alternatively, the driving force of rOAT1 and rOAT3
activity could be depressed in renal tubular cells of I/R
kidney. rOAT1 and rOAT3 are known to mediate exchange
of anionic substrates with dicarboxylic acids, including
a-ketoglutarate, where the concentration in the cytoplasm
is much higher than in the serum, producing an outward-
directed driving force for influx of anionic substrates.33,34
Naþ /Kþ -ATPase actively pumps Naþ out of the renal
proximal tubule cells sustaining an inwardly directed Naþ
gradient.35 The inward movement of Naþ drives the uptake
of a-ketoglutarate by Naþ /dicarboxylate cotransporter 3.35
The depression of Naþ /Kþ -ATPase expression in the
ischemic rat kidney eliminates the inward Naþ gradient,
thereby decreasing uptake of a-ketoglutarate by Naþ /
dicarboxylate cotransporter 3. The protein level of Naþ /
Kþ -ATPase in the ischemic rat kidney was significantly
restored to the expression level found in the control rat
kidney by ingestion of cobalt. In ischemic renal tubules, the
driving force may not be fully maintained, thereby
resulting in reduced uptake of IS via rOAT3. The preventive
effect of cobalt intake on the level of serum IS could involve
restoration of the driving force for the rOAT1 and rOAT3
transporters. Cobalt intake might block the production of
factors that decrease the driving force for these transporters.
Alternatively, the activity of the efflux transporter(s) for IS at
the apical membrane of renal tubules, which is reduced by
I/R, might be restored by ingestion of cobalt. The precise
mechanism involved in the relationship between the levels of
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Figure 6 | Renal uptake of PAH and ES in control and ischemic
rats with or without cobalt intake. (a) PAH and (b) ES accumulation
by renal slices of control and ischemic rats at 48 h after ischemia.
Renal slices from control (J) and ischemic rats (K) were incubated
at 371C in incubation buffer containing 5 mM [14C]PAH or 5 mM [3H]ES,
for the period indicated. D-[3H]Mannitol or [14C]mannitol was used to
estimate the extracellular trapping and nonspecific uptake of
[14C]PAH or [3H]ES, respectively. Each point represents the
mean7s.e.m. for three to five slices. *Po0.05, **Po0.01, significantly
different from control rats at same period. The renal uptake clearance
of (c) PAH and (d) ES in control and ischemic rats with or without
cobalt intake at 48 h after ischemia. Renal slices from rats were
incubated at 371C in incubation buffer containing 5 mM [14C]PAH or
5 mM [3H]ES, for 60 min. *Po0.05, **Po0.01, significantly different
from control rats with or without cobalt intake; #Po0.05, significantly
different from ischemic rats without cobalt intake.
544 Kidney International (2007) 71, 539–547
o r i g i n a l a r t i c l e T Matsuzaki et al.: Downregulation of OATs in ischemic rat kidney
serum IS and the expression levels of OATs and the I/R-
induced downregulation of these transporters should be
further studied.
It was reported that the level of P-glycoprotein increased
in rat kidney after glycerol-induced ARF.36 In this study, we
found that renal rMdr1 mRNA showed a transient upregula-
tion during I/R of the rat kidney. To our knowledge, this is
the first report indicating upregulation of rMdr1 in the
kidney after I/R injury. Mdr1 is one of the known genes
transcriptionally regulated by hypoxia-inducible factor 1
under hypoxic conditions.17 Therefore, it is suggested that
hypoxia-inducible factor 1 induced by ischemia stimulates
the transient induction of rMdr1 gene. However, there was
no significant difference in the P-glycoprotein level between
the control and the ischemic rats at 48 h after ischemia, as
found in the rMdr1 mRNA expression. P-glycoprotein may
be upregulated during the early stage of ischemia, thereby
preventing tubular cell derangement by secreting cytotoxic
substances produced in ischemic kidney.
In conclusion, we report that I/R of rat kidney induces the
serum accumulation of IS, which could be caused by the
downregulation of renal rOAT1 and rOAT3, accompanied by
decreased transport activities. Although ingestion of cobalt
ameliorates the progression of renal dysfunction, as evident
from the decrease in the level of BUN, SCr, and IS, it has no
significant effect on the expression of rOAT1 and rOAT3. ES
uptake in renal slices of ischemic rats suggests that ingestion
of cobalt causes a partial restoration of transport activity
of rOAT3, but not rOAT1. This study has increased
our understanding the mechanism of regulation and patho-
physiological implications of OATs of renal tubules as well as
the renal handling of anionic drugs and endogenous toxins
under ischemic ARF conditions.
MATERIALS AND METHODS
Materials
Cobalt chloride was obtained from Wako Pure Chemical Industries,
Ltd (Osaka, Japan). [6,7-3H(N)]-ES ammonium salt (2120 GBq/
mmol), D-[1-3H(N)]-mannitol (525.4 GBq/mmol), p-[Glycyl-14C]-
aminohippuric acid (1.95 GBq/mmol) and D-[1-14C]-mannitol
(1.89 GBq/mmol) were obtained from PerkinElmer Life and
Analytical Sciences (Boston, MA, USA). IS was obtained from
Sigma Chemical Co. (St Louis, MO, USA). All other chemicals used
were of the highest purity available.
Experimental animals
Male Sprague–Dawley rats, initially weighing 150–180 g (Crea Japan
Inc., Tokyo, Japan), were housed in a standard animal maintenance
facility at constant temperature (21–231C), humidity (50–70%), and a
12:12 h light/dark cycle for at least 1 week before the day of the
experiment. All animal experiments were conducted according to the
guidelines of Kumamoto University for the care and use of laboratory
animals. Rats in the control group were given tap water, whereas rats
in the cobalt-intake group were given water containing 2 mM cobalt
chloride 24 h before the induction of ischemic injury to kill.
Rats were anesthetized using sodium pentobarbital (50 mg/kg
intraperitoneally), and placed on a heating plate (391C) to maintain
a constant temperature. The kidneys were exposed via midline
abdominal incisions. Renal ischemia was induced by vascular
clamps (AS ONE, Osaka, Japan) over both pedicles for 30 min.
After the clamps were released, the incision was closed in two layers
with 3–0 sutures. Sham animals (control) underwent anesthesia,
laparotomy, and renal pedicle dissection only. All animals received
warm saline solution instilled in the peritoneal cavity during the
surgical procedure, and were then allowed to recover with ad libitum
access to food and water. Animals were killed under surgical
anesthesia at 6, 12, 24, and 48 h after experimental intervention.
Blood samples were collected for measurement of SCr,
BUN, sodium (Na), chloride (Cl), and potassium (K) in serum.
A 50 ml aliquot of serum was added directly to 100 ml of methanol.
After centrifugation at 3000 g for 10 min, the supernatant
was assayed by high-performance liquid chromatography. For
histological assessment, kidney samples were fixed in 4%
buffered formaldehyde. Paraffin sections of the excised kidney
were stained with hematoxylin–eosin reagent. For semiquanti-
tative analysis of morphologic change, 10 high-magnification
fields (0.0675 mm2) of outer stripe and inner stripe of
outer medulla in rats were randomly selected. Then, tubular injury
was graded with an arbitrary score of 0–3: 0, the absence of
necrosis; 1, mild; 2, moderate; and 3, severe. All quantification was
performed in a blinded manner.
High-performance liquid chromatography determination
of IS
The high-performance liquid chromatography system consisted of a
Shimadzu LC-10ADVP pump and a Shimadzu RF-10AXL fluores-
cence spectrophotometer. A column of LiChrosorb RP-18 (Cica
Merck, Tokyo, Japan) was used as the stationary phase and the
mobile phase consisted of acetate buffer (0.2 M, pH 4.5). The flow
rate was 1.0 ml/min. IS was detected by means of a fluorescence
monitor (excitation 280 nm, emission 375 nm).
mRNA isolation and cDNA synthesis
For mRNA extraction, MagNA Pure LC mRNA Isolation Kit II
(Roche Diagnostics, Basel, Switzerland) was used according to the
instruction manual. In this automated process, the tissue samples
were dissolved in a buffer containing a chaotropic salt and an RNase
inactivator. The samples were homogenized with Lysing Matrix D
(Qbiogene Inc., Morgan Irvine, CA, USA) and FastPrep (Qbiogene
Inc.) at an oscillation speed of 4.5 for 30 s. The 30-poly (Aþ )
from the released mRNA hybridizes to the added biotin-
labeled oligo(dT). This complex is immobilized onto the surface
of streptavidin-coated magnetic beads. After a DNase digestion step,
unbound substances were removed by several washing steps, and
purified mRNA was eluted (elution volume, 50 ml) with a low-salt
buffer. cDNA was synthesized by using High-Capacity cDNA
Archive Kit (Applied Biosystems Inc., Foster City, CA, USA).
Briefly, 50 ml of mRNA substrate, 10 ml of reverse transcription (RT)
buffer, 4 ml of dNTP mixture, 10 ml of RT random primers, 5 ml of
MultiScribe reverse transcriptase, and 21 ml of nuclease-free water
were used for cDNA synthesis. After each reverse transcription,
cDNA was stored at 301C.
Real-time polymerase chain reaction
We performed a TaqMan quantitative real-time RT polymerase
chain reaction using ABI PRISM 7900 sequence to determine
the expression level of rOAT1, rOAT3, rMdr1a and eukaryotic
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18S ribosomal RNA (18 S rRNA). TaqMan 18S rRNA control
reagents, the primer sets and products of TaqMan Gene Expression
Assays were purchased from Applied Biosystems Inc. as follows:
rOAT1, Rn00568143_m1; rOAT3, Rn00580082_m1; rMdr1a,
Rn00591394_m1; and 18S rRNA, 4319413E.
Western blot analysis
Kidneys were homogenized in a homogenization buffer comprising
230 mM sucrose, 5 mM Tris-HCl, pH 7.5, 2 mM ethylenediaminete-
traacetic acid, 0.1 mM phenylmethanesulfonyl fluoride, 1 mg/ml
leupeptin, and 1 mg/ml pepstatin A. After measurement of the
protein content using a bicinchoninic acid protein assay reagent
(Pierce, Rockford, IL, USA), each sample was mixed in a loading
buffer (2% sodium dodecyl sulfate, 125 mM Tris-HCl, 20% glycerol,
5% 2-mercaptoethanol) and heated at 1001C for 2 min. The sample
were separated by 7.5% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and transferred onto polyvinylidene difluoride
membranes (Immobilon-P; Millipore, Bedford, MA, USA) by
semi-dry electroblotting. The blots were blocked overnight at 41C
with 2% ECL advance Blocking agents (GE Healthcare Bio-sciences
Corp., Piscataway, NJ, USA) in Tris-buffered saline containing 0.3%
Tween 20, and incubated 1 h at room temperature with primary
antibody specific for rOAT1, rOAT3, P-gp (C219 monoclonal
antibody, Signet Laboratories, Dedham, MA, USA), Naþ /Kþ -
ATPase a-1 subunit (Upstate Biotechnology Inc., Lake Placid, NY,
USA) or b-actin (Sigma Chemical Co.). The blots were washed with
Tris-buffered saline containing 0.3% Tween 20 and incubated with
the secondary antibody (horseradish peroxidase-linked antirabbit
immunoglobulin F (ab)2 or horseradish peroxidase-linked anti-
mouse immunoglobulin F(ab)2, GE Healthcare Bio-sciences Corp.)
for 1 h at room temperature. Immunoblots were visualized with an
ECL system (ECL Advance Western Blotting Detection Kit, GE
Healthcare Bio-sciences Corp.). The relative amount of each band
was determined densitometrically using Densitograph Imaging
Software (ATTO Corporation, Tokyo, Japan). Densitometric ratios
to control rats were used as the reference and accorded an arbitrary
value of 100.
Uptake by rat renal slices
Uptake studies by using isolated rat renal slices were carried out as
described in a previous report.37 Briefly, slices of whole kidney from
control and ischemic rats with or without the cobalt intake were
stored in ice-cold oxygenated incubation buffer composed of
120 mM NaCl, 16.2 mM KCl, 1 mM CaCl2, 1.2 mM MgSO4, and
10 mM NaH2PO4/Na2HPO4, pH7.5. Renal slices were randomly
selected and placed for incubation in flasks containing 6 ml of the
incubation buffer with [14C]PAH (5 mM, 0.37 kBq/ml) or [3H]ES
(5mM, 1.85 kBq/ml). The uptake of these compounds was carried
out at 371C under an atmosphere of 100% oxygen. [3H]Mannitol
(5mM, 1.85 kBq/ml) was used to calculate the extracellular
trapping and nonspecific uptake of [14C]PAH as well as to evaluate
the viability of slices. [14C]Mannitol (5mM, 0.37 kBq/ml) was
used for [3H]ES. After incubation for a specified period, the
incubation buffer containing radiolabeled compounds was
rapidly removed from the flask, washed twice with 5 ml of ice-
cold phosphate buffered saline, blotted on filter paper, weighed,
and solubilized in 0.5 ml of NCSII (GE Healthcare Bio-sciences
Corp.). The amount of radioactivity was then determined in a
liquid scintillation counter after adding 5 ml of OCS (GE Healthcare
Bio-sciences Corp.).
Statistical analysis
Data were analyzed statistically by analysis of variance and Scheffe’s
multiple comparison test, unpaired t-test or Mann–Whitney’s test.
A P-value of less than 0.05 was considered statistically significant.
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